Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - sale of implants and devices for spinal surgery (68.6%); - distribution of medical equipment (31.3%). Net sales are distributed geographically as follows: France (35.6%), the United States (30.8%) and other (33.6%).

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-15 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
23/07/26	€0.1760	+0.80%	350
22/07/26	€0.1746	-0.23%	14,358
21/07/26	€0.1750	+5.42%	70,680
20/07/26	€0.1660	-2.92%	24,253
17/07/26	€0.1710	-3.82%	68,837

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Real-time Euronext Paris Other stock markets 11:00:08 23/07/2026 +04			5-day change	1st Jan Change
0.1760 ^EUR	+0.80%		-1.01%	-11.34%

07-16	Implanet Installs 8i Robotics' Surgical Robot at French Hospital	MT
07-15	Implanet Installs 8I Robotics Multi-Arm Surgical Robot At Amiens-Picardie University Hospital	CI

Market Cap	25.11M 28.66M 23.31M 21.42M 40.36M 2.77B 40.96M 278M 109M 1.35B 108M 105M 4.67B	P/E 2024	-2.85x	P/E 2025	-5.8x
Enterprise Value	28.03M 31.99M 26.02M 23.91M 45.05M 3.09B 45.71M 310M 121M 1.51B 120M 117M 5.22B	EV / Sales 2024	2x	EV / Sales 2025	2.23x
Free-Float	33.85%	Yield 2024 *	-	Yield 2025	-

07-16	Implanet Installs 8i Robotics' Surgical Robot at French Hospital	MT
07-15	Implanet Installs 8I Robotics Multi-Arm Surgical Robot At Amiens-Picardie University Hospital	CI
07-07	Implanet S.A. Announces Unaudited Revenue Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-07	Implanet keeps the momentum going
07-06	Zonebourse agenda for company earnings: July 7, 2026
07-06	Zonebourse earnings calendar: week of July 6 to July 10, 2026
04-14	Implanet S.A. Reports Unaudited Revenue Results for the First Quarter Ended March 31, 2026	CI
04-13	Weekly Earnings Calendar: JPMorgan and Netflix in the US, LVMH and ASML in Europe,
03-27	Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-05	Shanghai Sanyou Medical's Implanet Secures FDA Clearance for 3D-Printed Spinal System	MT
03-04	Dassault Aviation, Scor... Stocks to Watch Today in Paris -
03-03	IMPLANET Receives FDA Clearance for the Swingo Anterior Cervical Cage	CI
03-03	Euroapi, JCDecaux, GTT... Stocks to Watch Tomorrow in Paris

07-15	IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital	BU
07-07	IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%	BU
06-25	IMPLANET to Sponsor Tech Talks at State of Spine Surgery Think Tank	BU
04-20	Minutes of IMPLANET’s Annual General Meeting Held on April 17, 2026	BU
04-14	IMPLANET Reports Q1 2026 Revenue of €3.03 Million, up 18%	BU

Implanet SA Stock

Stocks

ALIMP

FR0013470168

Medical Equipment, Supplies & Distribution

Valuation: Implanet SA

Chart: Implanet SA

Latest news : Implanet SA

Analysts' recommendations: Implanet SA

Press Releases: Implanet SA

News in other languages: Implanet SA

Quotes and Performance

Course Extremes

Managers and Directors: Implanet SA

Medical Devices & Implants

Financials

Company Profile

Quotes

Income Statement and Estimates

07-15	IMPLANET installe le robot chirurgical multi-bras 8i Robotics au CHU Amiens-Picardie
07-15	IMPLANET annonce l’installation de la solution 8i Robotics au CHU Amiens-Picardie
07-07	Implanet poursuit sur sa lancée
07-07	IMPLANET annonce un chiffre d’affaires semestriel 2026 en hausse de +23% à 7,1 M€
07-06	Agenda Zonebourse des résultats de sociétés : le 7 juillet 2026

1 day	+0.80%
1 week	-1.01%
Current month	+4.76%
1 month	-4.45%
3 months	-14.98%
6 months	-29.03%
Current year	-11.34%

1 week	0.16	0.18
1 month	0.15	0.19
Current year	0.15	0.29
1 year	0.14	0.45
3 years	0.04	0.45
5 years	0.04	0.84
10 years	0.04	73.2

Manager	Title	Age	Since
Ludovic Lastennet CEO	Chief Executive Officer	-	27/11/2012
David Dieumegard DFI	Director of Finance/CFO	-	01/09/2015
Yvanna Peigné COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Jean-Gérard Galvez CHM	Chairman	71	06/04/2011
Ludovic Lastennet BRD	Director/Board Member	-	22/01/2013
Paula Ness Speers BRD	Director/Board Member	-	10/06/2014

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMPLANET SA	+0.80%	-1.01%	+10.00%	+6.02%	28.66M
STRYKER CORPORATION	-1.70%	-2.28%	-21.74%	+4.62%	119B
SMITH & NEPHEW PLC	-0.42%	-2.78%	-1.63%	-7.02%	12.59B
GLAUKOS CORPORATION	-0.15%	-2.54%	+58.63%	+104.19%	8.97B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+8.70%	+15.33%	-41.19%	-66.00%	4.84B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.11%	-9.10%	+0.60%	+39.57%	2.65B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.70%	-1.80%	-8.42%	-21.88%	1.64B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.89%	-7.06%	-23.89%	-32.36%	1.61B
ENOVIS CORPORATION	-2.03%	+3.75%	-2.53%	-59.29%	1.53B
Average	+0.45%	-1.24%	-3.35%	-3.57%	16.93B
Weighted average by Cap.	-1.15%	-1.99%	-15.26%	+6.57%

	2024	2025
Net sales	9.41M 10.73M 8.73M 8.02M 15.12M 1.04B 15.34M 104M 40.71M 507M 40.3M 39.43M 1.75B	12.47M 14.24M 11.58M 10.64M 20.05M 1.37B 20.35M 138M 53.99M 672M 53.44M 52.29M 2.32B
Net income	-4.37M -4.98M -4.05M -3.72M -7.02M -481M -7.12M -48.29M -18.9M -235M -18.71M -18.3M -813M	-4.38M -5M -4.07M -3.74M -7.04M -483M -7.15M -48.46M -18.97M -236M -18.77M -18.37M -816M
Net Debt	4.57M 5.21M 4.24M 3.9M 7.34M 503M 7.45M 50.53M 19.78M 246M 19.57M 19.15M 851M	2.92M 3.33M 2.71M 2.49M 4.69M 321M 4.75M 32.24M 12.62M 157M 12.49M 12.22M 543M